Group 1 - The company, Unisoc, stated on September 3 that it will maintain a strong investment in research and development in the first half of 2025 [2] - The company has achieved 26 invention patents and 6 utility model patents [2] - The core technologies and key products of the company will continue to iterate [2]

Group 1 - The core viewpoint of the article is that Unigroup Guowei is expanding its special integrated circuit business into new application scenarios such as commercial aerospace, building on its traditional business foundation [2]

Group 1 - Since August, the A-share market has seen a significant increase in public fund research activity, with 163 public institutions participating in company research, covering 771 companies across 30 industries, and a total of 8,338 research instances, representing a month-on-month increase of 144.73% [1] Group 2 - The pharmaceutical and biotechnology sector was the most researched, with a total of 1,373 research instances covering 100 stocks, making it the highest focus area for public institutions in August; the electronics sector followed with 1,312 research instances covering 108 stocks [2] - Key companies in the pharmaceutical sector, such as Mindray Medical (300760), BeiGene, and Aibo Medical, were frequently researched, with a focus on innovative drug development, medical equipment updates, and the impact of centralized procurement policies [2] Group 3 - In the electronics sector, companies like Crystal Optoelectronics (002273), Unisoc (002049), and Industrial Fulian (601138) were core focuses due to their advancements in optical components and smart terminal manufacturing [2] - In the telecommunications sector, Tianfu Communication (300394) was the most researched company with 87 instances, focusing on the expansion of high-speed optical module capacity and the commercialization of silicon photonics technology [3] Group 4 - Public fund research activities showed a significant head effect, with 134 out of 163 participating institutions conducting more than 10 research instances, indicating a concentration of interest among top institutions [4] - Notable institutions included Bosera Fund with 200 research instances, followed by Harvest Fund (177 instances), Huaxia Fund (149 instances), and Guotai Fund (147 instances) [4] Group 5 - Research in August indicated a clear policy direction, with the pharmaceutical sector's rising interest linked to policy implementation, focusing on equipment updates and accelerated approval of innovative drugs [4] - The electronics sector maintained interest in cutting-edge fields such as optical technology and AI chips, despite a slight decrease in total research instances [4] - Increased research frequency in the machinery and power equipment sectors suggests institutional attention on inventory cycles bottoming out and a recovery in capital expenditure [4]

Core Viewpoint - The leading chip ETF (159801) experienced a decline of 2.35% at the opening, indicating a bearish trend in the semiconductor sector [1] Group 1: ETF Performance - The leading chip ETF (159801) opened at 0.830 yuan, reflecting a decrease of 2.35% [1] - Since its establishment on January 20, 2020, the ETF has achieved a return of 68.86% [1] - The ETF's return over the past month stands at 32.77% [1] Group 2: Major Holdings Performance - Major holdings in the ETF include: - SMIC (中芯国际) down 4.38% [1] - Haiguang Information (海光信息) down 2.58% [1] - Cambricon (寒武纪) down 6.80% [1] - Northern Huachuang (北方华创) down 4.27% [1] - OmniVision (豪威集团) unchanged at 0.00% [1] - Lattice Semiconductor (澜起科技) down 2.00% [1] - Zhongwei Company (中微公司) down 2.44% [1] - Zhaoyi Innovation (兆易创新) down 1.61% [1] - Changdian Technology (长电科技) up 0.12% [1] - Unisoc (紫光国微) down 0.62% [1] Group 3: Management and Benchmark - The ETF is managed by GF Fund Management Co., Ltd. [1] - The performance benchmark for the ETF is the National Securities Semiconductor Chip Index return [1]

半导体ETF南方（159325）业绩比较基准为中证半导体行业精选指数收益率，管理人为南方基金管理股 份有限公司，基金经理为赵卓雄、何典鸿，成立（2024-10-31）以来回报为46.37%，近一个月回报为 32.29%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 8月29日，半导体ETF南方（159325）开盘跌1.23%，报1.450元。半导体ETF南方（159325）重仓股方 面，中芯国际开盘跌4.38%，北方华创跌4.27%，海光信息跌2.58%，寒武纪跌6.80%，豪威集团涨 0.00%，澜起科技跌2.00%，兆易创新跌1.61%，中微公司跌2.44%，长电科技涨0.12%，紫光国微跌 0.62%。 来源：新浪基金∞工作室 ...

Group 1 - The article highlights a trend of decreasing shareholder accounts among 658 companies, with 97 companies experiencing a decline for more than three consecutive periods, indicating a concentration of shares [1][2] - Notable companies with significant declines in shareholder accounts include Unisoc Microelectronics, which has seen a 27.88% drop over 13 periods, and ZTE Corporation, with a 16.17% decrease over 12 periods [1][2] - The article mentions that among the companies with decreasing shareholder accounts, 64 have seen their stock prices rise, while 33 have experienced declines, with notable gainers including Yidong Electronics, ZTE Corporation, and Chuangyitong, which have increased by 82.55%, 46.31%, and 45.50% respectively [2] Group 2 - In terms of industry distribution, the companies with decreasing shareholder accounts are primarily concentrated in the basic chemicals, machinery equipment, and electronics sectors, with 14, 11, and 8 companies respectively [2] - The main board has 62 companies with decreasing shareholder accounts, while the ChiNext board has 33, and the Sci-Tech Innovation board has 2 [2] - Among the companies that have reported their semi-annual results, Fujilai has the highest year-on-year net profit growth of 12430.96%, while Nanshan Holdings is expected to have a net profit median of 92 million, reflecting a year-on-year increase of 177.84% [3]

Core Viewpoint - The stock of Unisoc Microelectronics has shown significant growth this year, with a 30.30% increase, and has been actively traded with notable capital inflows and outflows [1][2]. Group 1: Stock Performance - As of August 28, Unisoc Microelectronics' stock price rose by 2.04% to 83.60 CNY per share, with a trading volume of 1.503 billion CNY and a turnover rate of 2.15%, resulting in a total market capitalization of 71.029 billion CNY [1]. - Year-to-date, the stock has increased by 30.30%, with a 3.92% rise in the last five trading days, 20.22% in the last 20 days, and 29.35% in the last 60 days [1]. Group 2: Financial Performance - For the first half of 2025, Unisoc Microelectronics reported a revenue of 3.047 billion CNY, reflecting a year-on-year growth of 6.07%, while the net profit attributable to shareholders decreased by 6.18% to 692 million CNY [2]. - The company has distributed a total of 1.419 billion CNY in dividends since its A-share listing, with 750 million CNY distributed over the past three years [2]. Group 3: Shareholder Information - As of June 30, 2025, the top ten circulating shareholders of Unisoc Microelectronics include significant institutional investors, with Hong Kong Central Clearing Limited holding 16.7943 million shares, an increase of 597,000 shares from the previous period [3]. - Other notable shareholders include Huatai-PB CSI 300 ETF and Huaxia National Semiconductor Chip ETF, both of which have increased their holdings [3].

紫光国芯微电子股份有限公司 募集资金管理办法 (2025年8月修订) 第一章 总则 第一条 为规范紫光国芯微电子股份有限公司（以下简称"公司"）募集资 金管理，提高募集资金使用效率，根据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司证券发行注册管理办法》《上市公司募集资金监管规则》 《深圳证券交易所股票上市规则》（以下简称《股票上市规则》）《深圳证券交 易所上市公司自律监管指引第1号——主板上市公司规范运作》等法律、法规、 规章、规范性文件及《紫光国芯微电子股份有限公司章程》（以下简称《公司章 程》）的有关规定，结合公司实际情况，制定本办法。 第二条 本办法所称募集资金是指公司通过发行股票或者其他具有股权性质 的证券，向投资者募集并用于特定用途的资金，不包括公司为实施股权激励计划 募集的资金。 第三条 公司应当审慎使用募集资金，保证募集资金的使用与发行申请文件 的承诺相一致，不得擅自改变募集资金的投向。公司应当真实、准确、完整地披 露募集资金的实际使用情况。出现严重影响募集资金投资计划正常进行的情形时， 应当及时公告。 募集资金投资境外项目的，公司及保荐机构应当采取有效措施，确保投资于境 外项目 ...

紫光国芯微电子股份有限公司 信息披露暂缓与豁免管理制度 （2025 年 8 月制定） 第四条 公司和其他信息披露义务人应当审慎确定信息披露暂缓、豁免事项， 履行内部审核程序。 第五条 本制度所称"信息披露义务人"，包括公司及其董事、高级管理人 员、股东、实际控制人，收购人，重大资产重组、再融资、重大交易有关各方等 自然人、单位及其相关人员，破产管理人及其成员，以及法律、法规和中国证监 会规定的其他承担信息披露义务的主体。 第二章 暂缓与豁免披露信息的范围 第六条 公司和其他信息披露义务人有确实充分的证据证明拟披露信息涉及 国家秘密（指国家有关保密法律、法规及部门规章规定的，关系国家安全和利益， 依照法定程序确定，在一定时间内只限一定范围的人员知悉，泄露后可能损害国 家在政治、经济、国防、外交等领域的安全和利益的信息。）或者其他因披露可 能导致违反国家保密规定、管理要求的事项（以下统称"国家秘密"），依法豁 免披露。 第七条 公司和其他信息披露义务人有保守国家秘密的义务，不得通过信息 披露、投资者互动问答、新闻发布、接受采访等任何形式泄露国家秘密，不得以 第一章 总则 第一条 为规范紫光国芯微电子股份有限公司（ ...

| 证券代码：002049 | 证券简称：紫光国微 | 公告编号：2025-082 | | --- | --- | --- | | 债券代码：127038 | 债券简称：国微转债 | | 紫光国芯微电子股份有限公司 第八届董事会第二十九次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 紫光国芯微电子股份有限公司（以下简称"公司"）第八届董事会第二十九 次会议通知于 2025 年 8 月 25 日以电子邮件的方式发出，会议于 2025 年 8 月 27 日以通讯表决的方式召开，会议应出席董事 7 人，实际出席董事 7 人。会议由董 事长陈杰先生召集并主持。公司部分高级管理人员列席了会议。会议的召集、召 开和表决程序符合《中华人民共和国公司法》和《紫光国芯微电子股份有限公司 章程》的规定。 经与会董事审议，会议形成如下决议： 具体内容详见公司于同日在巨潮资讯网（http://www.cninfo.com.cn）上披 露的《募集资金管理办法（2025 年 8 月修订）》。 2．会议以 7 票同意、0 票反对、0 票弃权的表决结果审议通过《关于制定< 信 ...